| Literature DB >> 35734346 |
Alexandru O Doma1, Romeo T Cristina1, Florin Muselin1, Eugenia Dumitrescu1, János Dégi1, Kálman Imre1, Marius Boldea1, Daliborca C Vlad2, Roxana Popescu2, Adinela Cimporescu2, Dana C Bratu2.
Abstract
Background: The bacterial membrane plays a critical role in the survival of bacteria and the effectiveness of antimicrobial peptides in protecting the host. The lipid constituents of the bacterial membrane are not evenly distributed, and they could be affected by clustering anionic lipids with cationic peptides with multiple positive charges. That could be harmful to bacteria because it prevents lipids from interacting with other molecular components of the cell membrane, disrupts existing natural domains, or creates phase boundary defects between the clustered lipids and the bulk of the membrane. This preliminary quantitative study is aimed at assembling a correlation between antibiotic resistance and bacterial lipid composition in E. coli, based on the function and arrangement of the bilipid coating of the bacterial cell, intimately associated with the path of antimicrobials through membranes.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35734346 PMCID: PMC9209004 DOI: 10.1155/2022/6028045
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.246
Sample preparation and reagents used.
| Phase | Substances used |
|---|---|
| Saponification | Reagent 1: |
| Methylation | Reagent 2: |
| Extraction | Reagent 3: |
| Rinse | Reagent 4: |
The antibiotic susceptibility results according to CLSI 2018 [29].
| Crt. No. | Sample no./antibiotic tested | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | Amoxicillin | R | R | R | R | R | R | R | R | R | R | R |
| 2. | Gentamycin | S | S | S | S | S | S | S | S | S | S | S |
| 3. | Florfenicol | R | S | R | S | R | S | R | R | R | R | R |
| 4. | Oxacillin | S | R | R | R | R | S | S | S | S | S | S |
| 5. | Cephalothin | R | R | R | R | R | R | R | R | R | R | R |
| 6. | Spectinomycin | R | R | R | R | R | S | R | R | R | R | S |
| 7. | Norfloxacin | R | S | S | S | S | S | R | R | S | R | S |
| 8. | Tiamulin | S | S | S | S | S | S | S | S | R | S | S |
| 9. | Ciprofloxacin | S | S | R | R | R | S | R | S | R | S | R |
| 10. | Penicillin | R | S | R | R | R | S | S | R | R | R | S |
| 11. | Tetracycline | R | R | R | R | R | S | S | R | S | R | R |
Note: R: resistant; S: sensitive.
Figure 1The chromatograms of the identified fatty acids.
Quantification of results and highlighting of fatty acids in the bacterial membrane.
| Retention time (min.) | Identified compound | No. of collection dial (chromatogram) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | ||
| 8.2 | Decanoic acid (methyl ester) | − | + | − | − | + | − | − | − | − | − | − |
| 10.3 | 4-Octadecenal | − | − | − | − | − | + | − | − | − | − | − |
| 10.6 | Methyl-10-methyl undecanoate | − | + | + | + | + | + | + | + | + | + | + |
| 13.8 | Methyl-(Z)-11-tetradecenoate | − | − | − | − | − | + | − | − | − | − | − |
| 14.3 | Methyl-iso-myristate | + | + | + | + | + | + | + | + | + | − | + |
| 15.7 | Methyl-(Z)-11-tetradecenoate | − | − | − | − | − | − | − | − | − | + | + |
| 17.2 | I-propyl-tetradecanoate | + | + | + | + | + | + | + | + | + | + | + |
| 20.1 | Methyl-palmitoleate | + | + | + | + | + | − | − | − | + | + | − |
| 20.2 | Methyl-hexadec-9-enoate | − | + | − | − | − | + | + | − | − | − | + |
| 21.3 | Methyl-14-methyl-pentadecanoate | − | − | − | + | − | + | + | + | − | − | + |
| 21.4 | Methyl-3-(3.5-di-tert-butil-4-hidroxy-phenyl) propionate | + | − | − | − | − | − | − | − | − | − | − |
| 26.0 | Methyl-8-heptadecenoate | − | + | − | − | − | − | − | − | + | − | − |
| 26.1 | Methyl-9,10-metylene-hexadecanoate | − | − | + | − | − | + | + | − | − | + | + |
| 26.1 | Cis-10-heptadecenoic-acid (methyl ester) | + | − | − | + | + | − | − | − | − | − | − |
| 29.0 | Methyl-(10E)-10-octadecenoate | − | − | − | + | − | − | − | − | − | − | − |
| 29.0 | Methyl-11-octadecenoate | + | − | − | − | + | + | − | − | − | − | − |
| 29.0 | Methyl-trans-8-octadecenoate | − | + | − | − | − | − | − | − | − | − | − |
| 29.1 | Methyl-13-octadecenoate | − | − | − | − | − | − | − | − | − | − | + |
| 29.5 | Methyl-16-methyl-heptadecanoate | − | − | + | + | + | − | + | − | + | − | − |
| 29.5 | Methyl-14-methyl-heptadecanoate | − | + | − | − | − | + | − | − | − | + | + |
| 30.4 | Decanoic acid (decyl ester) | + | + | − | − | − | + | − | + | − | + | + |
| 31.2 | Methyl-dihydrosterculate | − | − | − | − | − | − | − | − | − | + | − |
| 31.2 | Methyl-9,10-metilene-octadecanoate | − | − | − | − | − | − | − | − | − | − | + |
Figure 2The descriptive statistic correlation between (a) the fatty acids vs. sensitive strains and (c) fatty acids vs. resistant strain presence/absence in the bacterial membrane, where a high significance correlation was registered for (b, c).
| Sample no. | Sensitive no. | Resistant no. | Fatty acid no. |
|---|---|---|---|
| 1 | 4 | 7 | 7 |
| 2 | 6 | 5 | 10 |
| 3 | 3 | 8 | 6 |
| 4 | 4 | 7 | 8 |
| 5 | 3 | 8 | 8 |
| 6 | 9 | 2 | 11 |
| 7 | 5 | 6 | 7 |
| 8 | 4 | 7 | 5 |
| 9 | 4 | 7 | 6 |
| 10 | 4 | 7 | 8 |
| 11 | 6 | 5 | 11 |
| Mean | 4.727272727 | 6.272727273 | 7.909090909 |
| Standard error | 0.523813101 | 0.523813101 | 0.609836721 |
| Median | 4 | 7 | 8 |
| Mode | 4 | 7 | 8 |
| Standard deviation | 1.737291518 | 1.737291518 | 2.022599587 |
| Sample variance | 3.018181818 | 3.018181818 | 4.090909091 |
| Kurtosis | 3.033156723 | 3.033156723 | -0.866962963 |
| Skewness | 1.629735293 | -1.629735293 | 0.416039579 |
| Range | 6 | 6 | 6 |
| Minimum | 3 | 2 | 5 |
| Maximum | 9 | 8 | 11 |
| Sum | 52 | 69 | 87 |
| Count | 11 | 11 | 11 |
| Confidence level (95.0%) | 1.167128323 | 1.167128323 | 1.358800892 |
| Sensitive | Resistant | Fatty acids | |||
|---|---|---|---|---|---|
| Lower | Higher | Lower | Higher | Lower | Higher |
| 4.7273-1.1671 | 17273 + 1.1671 | 6.2727 − 1.1671 | 6.2727 + 1.1671 | 7.9091 − 1.3588 | 7.9091 + 1.3588 |
| 3.560144 | 5.894401 | 5.105599 | 7.439856 | 6.55029 | 9.267892 |
| ANOVA | SS | dF | MS |
|
|
|---|---|---|---|---|---|
| Treatment (between columns) | 55.70 | 2 | 27.85 |
|
|
| Residual (within columns) | 101.30 | 30 | 3.37 | ||
| Total | 157 | 32 | 31.22 | ||
| ANOVA summary | |||||
|
| 8.25 | ||||
|
| 0.0014 | ||||
|
| ∗∗ | ||||
| Are differences among means statistically significant? ( | Yes | ||||
|
| 0.3548 | ||||
| Parameter | Fatty acids vs. sensitive | Fatty acids vs. resistant |
|---|---|---|
| Pearson | ||
|
| 0.7606 | -0.7606 |
| 95% confidence interval | 0.2955 to 0.9343 | -0.9343 to -0.2955 |
|
| 0.5786 | 0.5786 |
|
| ||
|
| 0.0066 | 0.0066 |
|
| ∗∗ | ∗∗ |
| Significant? (alpha = 0.05) | Yes | Yes |
| Number of | 11 | 11 |
| Summary | ||||
|---|---|---|---|---|
| Groups | Count | Sum | Average | Variance |
| Sensitive | 11 | 52 | 4.727272727 | 3.018182 |
| Resistant | 11 | 69 | 6.272727273 | 3.018182 |
| Fatty acids | 11 | 87 | 7.909090909 | 4.090909 |
(d) The matrix of statistical correlation
| Category | Sensitive | Resistant | Fatty acids |
|---|---|---|---|
| Sensitive | 1 | -1 | 0.760627515 |
| Resistant | -1 | 1 | -0.760627515 |
| Fatty acids | 0.760627515 | -0.760627515 | 1 |